Author:
Li Zhiyan,Ai Shichao,Wang Feng,Tao Liang,Sun Feng,Song Peng,Shen Xiaofei,Hu Qiongyuan,Li Xianghui,Liu Song,Wang Meng,Guan Wenxian
Abstract
Abstract
Background
The clinical application of robotic-assisted gastrectomy remains controversial, especially as clinical studies of this operation navigated by carbon nanoparticle suspension injection (CNSI) have not been conducted. This study aims to assess the perioperative safety and efficacy of CNSI-guided robotic-assisted gastrectomy in patients with gastric cancer by focusing on short-term outcomes.
Methods
A retrospective analysis of patients who underwent CNSI-guided laparoscopic or robotic-assisted gastrectomy with a pathological diagnosis of gastric cancer was conducted. Data on demographics, surgical management, clinical-pathological results and short-term outcomes were compared among the groups.
Results
A total of 126 eligible patients were separated into the robotic-assisted gastrectomy (RAG) group (n = 16) and the laparoscopic gastrectomy (LG) group (n = 110) in total. The operation time of the RAG group is longer than the LG group (p = 0.0000). When it comes to perioperative and short-term complications, there exists no statistical difference between the two groups.
Conclusion
The time required for CNSI-guided robotic-assisted gastrectomy is longer than that for CNSI-guided laparoscopic gastrectomy. CNSI-guided robotic-assisted gastrectomy is safe and effective.
Funder
Natural Science Foundation for Young Scholars of Jiangsu Province
Natural Science Foundation of Jiangsu Province
National Natural Science Foundation of China
Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University
Publisher
Springer Science and Business Media LLC